Rankings
Publications
Sources
Publishers
Scholars
Organizations
About
Login
Register
Home
Publications
Implications of the new FDA/CDER immunotoxicology guidance for drugs.
Home
Publications
Implications of the new FDA/CDER immunotoxicology guidance for drugs.
Implications of the new FDA/CDER immunotoxicology guidance for drugs.
Kenneth L. Hastings
Kenneth L. Hastings
Publisher Website
Google Scholar
Cite
Download
Share
Download
18 June 2002
journal article
guideline
Published by
Elsevier BV
in
International Immunopharmacology
Vol. 2
(11)
,
1613-1618
https://doi.org/10.1016/s1567-5769(02)00061-9
Abstract
No abstract available
Keywords
PHARMACEUTICALS
FUNCTION
DRUGS
ADVERSE EFFECTS
GUIDANCE
IMMUNE EFFECTS
IMMUNOTOXIC POTENTIAL
NEW FDA/CDER
Cited by 24 articles